BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Press Releases

  Nyxoah Appoints Scott Holstine as Chief Commercial Officer

  July 15, 2024

   · 

  6 min read
• Press Releases

  GRAIL Advances the Galleri® Registrational Clinical Trial Program

  July 15, 2024

   · 

  10 min read
• Press Releases

  Lexeo Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy

  July 15, 2024

   · 

  8 min read
• Press Releases

  Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds

  July 15, 2024

   · 

  5 min read
• Press Releases

  Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study

  July 15, 2024

   · 

  12 min read
• Press Releases

  Modicus Prime Raises $3.5M to prevent Drug Product Quality failures during Commercial Production

  July 15, 2024

   · 

  4 min read
• Press Releases

  Sol-Gel Technologies Announces Management Realignment

  July 15, 2024

   · 

  6 min read
• Press Releases

  Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference

  July 15, 2024

   · 

  15 min read
• Press Releases

  GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research

  July 15, 2024

   · 

  8 min read
• Press Releases

  FDA Roundup: July 12, 2024

  July 15, 2024

   · 

  4 min read